Original language | English |
---|---|
Pages (from-to) | 162-162 |
Number of pages | 1 |
Journal | Clinical Pharmacology and Therapeutics |
Volume | 59 |
Issue number | 2 |
Publication status | Published - 1996 |
Cite this
Rieder, MJ., Almawi, WY., Hess, DA., Kaidbey, HH., Chudzik, DM., & Assi, JW. (1996). Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7. Clinical Pharmacology and Therapeutics, 59(2), 162-162.
Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7. / Rieder, MJ; Almawi, WY; Hess, DA; Kaidbey, HH; Chudzik, DM; Assi, JW.
In: Clinical Pharmacology and Therapeutics, Vol. 59, No. 2, 1996, p. 162-162.Research output: Contribution to journal › Article
Rieder, MJ, Almawi, WY, Hess, DA, Kaidbey, HH, Chudzik, DM & Assi, JW 1996, 'Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7', Clinical Pharmacology and Therapeutics, vol. 59, no. 2, pp. 162-162.
Rieder MJ, Almawi WY, Hess DA, Kaidbey HH, Chudzik DM, Assi JW. Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7. Clinical Pharmacology and Therapeutics. 1996;59(2):162-162.
@article{e0125c2e629e413b8d37fb3931373a8e,
title = "Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7",
author = "MJ Rieder and WY Almawi and DA Hess and HH Kaidbey and DM Chudzik and JW Assi",
year = "1996",
language = "English",
volume = "59",
pages = "162--162",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "2",
}
TY - JOUR
T1 - Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7
AU - Rieder, MJ
AU - Almawi, WY
AU - Hess, DA
AU - Kaidbey, HH
AU - Chudzik, DM
AU - Assi, JW
PY - 1996
Y1 - 1996
M3 - Article
VL - 59
SP - 162
EP - 162
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
SN - 0009-9236
IS - 2
ER -